Heart failure related to hyperthyroidism in young woman

Authors

  • Kadek Adi Sudarmika Sanjiwani General Public Hospital, Gianyar, Bali, Indonesia
  • Ni Luh Eka Sriayu Wulandari Department of Cardiology and Vascular Medicine, Sanjiwani General Public Hospital, Gianyar, Bali, Indonesia

DOI:

https://doi.org/10.18203/2349-3933.ijam20243064

Keywords:

Acute decompensated heart failure, Hyperthyroidism, Cardiogenic shock

Abstract

Acute decompensated heart failure is a clinical condition that is precipitated by underlying pathology, including thyroid disorders. The condition of hyperthyroidism can result in a hyperactive circulation, which can increase cardiac output and metabolic demands, ultimately leading to heart failure. A 35-year-old woman presented to the hospital with acute shortness of breath that increased during the night, as well as bilateral edema in the lower extremities, palpitations, and intermittent chest pain. According to the patient's medical history, hyperthyroidism was diagnosed two years ago; however, the patient has not adhered to the prescribed treatment. The physical examination shows low blood pressure (80/60 mmHg), tachycardia, and increased jugular venous pressure. Lung auscultation detects bilateral fine crackles. A decrease in ejection fraction is evident on echocardiography. The laboratory results indicated hyperthyroidism. Initial treatment includes a saline infusion, a dobutamine infusion, a high-dose furosemide drip, acetazolamide as an extra diuretic, clopidogrel, atorvastatin, isosorbide dinitrate under the tongue, sacubitril/valsartan, spironolactone, and enoxaparin. This case highlights the importance of recognizing the multifactorial nature of heart failure, especially in patients with hyperthyroidism.

Metrics

Metrics Loading ...

References

Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53(7):557-73.

Hussein M, Toraih E, Reisner ASC, Miller P, Corsetti R, Kandil E. Prevalence and mortality of cardiovascular events in patients with hyperthyroidism: a nationwide cohort study in the United States. Gland Surg [Internet]. 2021;10(9):2608-21.

Doodnauth Yacoub F, Solanki V, Trimmingham A, Soni LI, McFarlane S. NON-ST-segment elevation myocardial infarction associated with inadvertent thyroid hormone overdose. Am J Med Case Reports. 2021;9(3):194-7.

Sharma A, Stan MN. Thyrotoxicosis: diagnosis and management. Mayo Clin Proc. 2019;94(6):1048-64.

De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906-18.

Ina Heart. Cardiovascular disease in Indonesia: facts and figures. Jakarta: Indonesian Heart Association. J Epidemiol Glob Health. 2024;14(1): 193–212.

Soesanto AM. Echocardiography detection of high-risk patent foramen ovale morphology. Indones J Cardiol. 2021;42(3):45-55.

Roger VL. Epidemiology of Heart Failure. Circ Res. 2013;113(6):646-59.

Kannan L, Shaw PA, Morley MP, Brandimarto J, Fang JC, Sweitzer NK, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Hear Fail. 2018;11(12):1-9.

Yamakawa H, Kato TS, Noh JY, Yuasa S, Kawamura A, Fukuda K, et al. Thyroid hormone plays an important role in cardiac function: from bench to bedside. Front Physiol. 2021;12:1-14.

Cappola AR, Desai AS, Medici M, Cooper LS, Egan D, Sopko G, et al. Thyroid and cardiovascular disease. circulation. 2019;139(25):2892–909.

Tallo NL, Sihombing ME. Kardiomiopati Tirotoksikosis. CDK-329. 2024;51(06):316–20.

Habibie M. Manifestasi Klinis dan Tatalaksana Penyakit Jantung Tiroid. J Kedokt Nanggroe Med. 2020;3(1):39-46.

Quiroz AJE, Durand VC, Lobato JCJ, Muñoz MJM, Gómez CDCD, Ildefonso NSP, et al. Thyrotoxic Cardiomyopathy: State of the Art. Eur Endocrinol. 2023;19(1):78.

Chen RJ, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J, et al. Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension. 2021;78(3):591-603.

Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll CardioL. 2018;71(13):1474-82.

Shirakabe A, Matsushita M, Shibata Y, Shighihara S, Nishigoori S, Sawatani T, et al. Organ dysfunction, injury, and failure in cardiogenic shock. J Intensive Care. 2023;11(1):1-9.

Nandita SP, Kuncahyo I, Harjanti R. Formulation and optimization of furosemide snedds with variation concentration of tween 80 and PEG 400. J Fundam Appl Pharm Sci. 2021;2(1):34–42.

Oh SW, Han SY. Loop diuretics in clinical practice. Electrolytes Blood Press. 2015;13(1):17.

Sihite, Abdullah H, MF K, Muhsin M, Azhari G, Muhammad D. Thyroid heart disease in young male, a case report perdana. J Soc Med. 2021;2(1):24-8.

Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. J Am Heart Assoc. 2019;8(8):1-12.

Lescroart M, Pequignot B, Janah D, Levy B. The medical treatment of cardiogenic shock. J Intensive Med. 2023;3(2):114-23.

Hudaja DN, Soetjipto AS, Ariyani QS, Soesanto M, Pardede IM. A case series coexistence of PFO with other conditions - who’s the culprit? Indones J Cardiol. 2021;42(3):90-9.

Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.

Downloads

Published

2024-10-24

How to Cite

Sudarmika, K. A., & Wulandari, N. L. E. S. (2024). Heart failure related to hyperthyroidism in young woman. International Journal of Advances in Medicine, 11(6), 599–602. https://doi.org/10.18203/2349-3933.ijam20243064